Chemotherapy Plus Cetuximab in Combination With VTX-2337 in Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck
Clinical trial NCT01836029 · COMPLETED
Trial details
- NCT number
- NCT01836029
- Sponsor
- Celgene
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-10-14
- Primary completion
- 2016-04-13
- Enrollment
- 195
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.